Health Care: Drugs

Nivalis Therapeutics Inc (NVLS: NASDAQ)

$2.85 0.12 | 4.4%
03/01/17 - 01:52 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 8.59M 6.84M 2.29M 2.14M
Research & Development 23.32M 16.05M 12.20M 13.14M
Operating Income before D & A (EBITDA) -31.90M -22.90M -14.49M -15.28M
Depreciation & Amortization 143.00K 66.00K 796.00K 740.00K
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 439.00K 80.00K 296.00K 10.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -31.61M -22.88M -14.99M -16.01M
Interest Expense 0.00 0.00 845.00K 931.00K
Pre-Tax Income -31.61M -22.88M -15.83M -16.94M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -31.46M -22.82M -15.04M -16.20M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -31.46M -22.82M -15.04M -16.20M
Extraordinary Income/Losses 0.00 0.00 378.00K 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -31.46M -22.82M -14.66M -16.20M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-31.46M -22.82M -15.04M -16.20M
Preferred Dividends
Net Income Available To Common -31.46M -22.82M -15.04M -16.20M
Basic EPS from Continuing Ops. -2.03 -2.43 0.00 0.00
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.03 -2.43 0.00 0.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.03 -2.43 0.00 0.00
Basic Normalized Net Income/Share -2.03 -2.43 n.a. n.a.
EPS fr Continuing Ops. -2.03 -2.43 0.00 0.00
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.03 -2.43 0.00 0.00
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.03 -2.43 0.00 0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.03 -2.43 n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NVLS

Latest NVLS Headlines from TheStreet

More Financial News for NVLS

Press Releases for NVLS

See All Press Releases

Partner Headlines for NVLS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter